scholarly journals Next generation sequencing: clinical applications in solid tumours

2017 ◽  
Vol 10 (4) ◽  
pp. 244-247 ◽  
Author(s):  
Leonhard Müllauer
Keyword(s):  
Next Generation Sequencing ◽  
Clinical Applications ◽  
Solid Tumours ◽  
Next Generation ◽  
Generation Sequencing

scholarly journals 1965P Detection of BRCA1/2 mutations using next-generation sequencing in Asian patients with solid tumours

2020 ◽  
Vol 31 ◽  
pp. S1105
Author(s):  
K.T. Tan ◽  
H-Y. Lu ◽  
Y-H. Jan ◽  
Y-L. Hsieh ◽  
D-W. Zhuo ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
Solid Tumours ◽  
Next Generation ◽  
Asian Patients ◽  
Generation Sequencing

Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours

2020 ◽  
Vol 73 (9) ◽  
pp. 602-604
Author(s):  
Silvia Bessi ◽  
Francesco Pepe ◽  
Marco Ottaviantonio ◽  
Pasquale Pisapia ◽  
Umberto Malapelle ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
High Performance ◽  
Solid Tumours ◽  
Next Generation ◽  
Formalin Fixed Paraffin ◽  
Ffpe Samples ◽  
Thermo Fisher Scientific ◽  
Formalin Fixed Paraffin Embedded ◽  
Sequencing Platforms ◽  
Generation Sequencing

In the present study, we analysed 44 formalin fixed paraffin embedded (FFPE) from different solid tumours by adopting two different next generation sequencing platforms: GeneReader (QIAGEN, Hilden, Germany) and Ion Torrent (Thermo Fisher Scientific, Waltham, Massachusetts, USA). We highlighted a 100% concordance between the platforms. In addition, focusing on variant detection, we evaluated a very good agreement between the two tests (Cohen’s kappa=0.84) and, when taking into account variant allele fraction value for each variant, a very high concordance was obtained (Pearson’s r=0.94). Our results underlined the high performance rate of GeneReader on FFPE samples and its suitability in routine molecular predictive practice.

Sign in / Sign up

Export Citation Format

Share Document